June 3, 2020 -- Global Healthcare Opportunities (GHO) has acquired X-Chem, a biotechnology company that provides drug discovery services via DNA-encoded library technology.
GHO plans to increase its technology and service proposition following the completion of the acquisition, according to the company.
X-Chem's proprietary DNA-encoded library platform contains over 200 billion small molecules that it can leverage for drug discovery services.
Matt Clark, co-founder of X-Chem and its current senior vice president, will be named its chief executive officer (CEO). Rick Wagner, co-founder and CEO of X-Chem, will resign from the company.